Chemed (NYSE:CHE) Stock Rating Upgraded by Wall Street Zen

Chemed (NYSE:CHE) was upgraded by Wall Street Zen from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday.

CHE has been the subject of several other research reports. Oppenheimer lifted their price objective on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a report on Wednesday. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Royal Bank Of Canada boosted their price target on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $530.75.

Chemed Stock Up 0.1%

CHE stock opened at $533.03 on Friday. Chemed has a fifty-two week low of $365.20 and a fifty-two week high of $551.68. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The stock has a market capitalization of $7.07 billion, a price-to-earnings ratio of 26.77, a PEG ratio of 2.02 and a beta of 0.51. The business’s fifty day moving average price is $467.11 and its two-hundred day moving average price is $436.50.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. During the same quarter in the previous year, the business posted $4.27 earnings per share. Chemed’s quarterly revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities analysts anticipate that Chemed will post 23.18 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.33% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Monetary Solutions Ltd bought a new stake in Chemed during the fourth quarter worth $25,000. Los Angeles Capital Management LLC bought a new position in shares of Chemed in the 4th quarter valued at $26,000. BOK Financial Private Wealth Inc. bought a new position in shares of Chemed in the 4th quarter valued at $27,000. Versant Capital Management Inc raised its holdings in shares of Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after buying an additional 75 shares in the last quarter. Finally, Global Retirement Partners LLC lifted its position in shares of Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after buying an additional 58 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.